From October 1, 2023 to November 17, 2023, the company has repurchased 6,106,800 shares, representing 0.54% for CNY 100.02 million. With this, the company has completed the repurchase of 9,015,780 shares, representing 0.8% for CNY 150 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 CNY | +0.47% | +0.47% | -0.53% |
04-29 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.53% | 2.49B | |
+31.59% | 588B | |
-3.20% | 364B | |
+19.55% | 326B | |
+5.14% | 285B | |
+15.55% | 239B | |
+10.18% | 210B | |
-7.16% | 200B | |
+9.01% | 167B | |
-0.47% | 161B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.